Concerns with Serum Institute of India’s AstraZeneca Vaccine (ChAdOx1 nCoV-19)

Concerns with Serum Institute of India’s AstraZeneca Vaccine (ChAdOx1 nCoV-19)
Prem Anand Murugan

Prem Anand Murugan is a Ph.D. student at the Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur.

Published on
Loading content, please wait...

Related Stories

No stories found.
The Leaflet
theleaflet.in